LL-K8-22

For research use only. Not for therapeutic Use.

  • CAT Number: I041373
  • Molecular Formula: C37H43N5O
  • Molecular Weight: 573.77
  • Purity: ≥95%
Inquiry Now

LL-K8-22(Cat No.:I041373)is a small molecule inhibitor that targets specific signaling pathways involved in cancer cell proliferation and survival. It is designed to inhibit certain kinases or enzymes that contribute to tumor growth, making it a potential therapeutic candidate for treating various cancers. LL-K8-22 has shown promise in preclinical studies for its ability to selectively block the activity of these critical proteins, thereby reducing tumor progression. Ongoing research is focused on evaluating its efficacy and safety in clinical trials, with the aim of developing it as a targeted cancer therapy.


Synonyms

1-[4-[3-(1-adamantyl)propyl]piperazin-1-yl]-2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]ethanone

Molecular Formula C37H43N5O
Purity ≥95%
IUPAC Name 1-[4-[3-(1-adamantyl)propyl]piperazin-1-yl]-2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]ethanone
InChI InChI=1S/C37H43N5O/c43-36(41-14-12-40(13-15-41)11-3-10-37-19-27-16-28(20-37)18-29(17-27)21-37)26-42-25-33(23-39-42)30-6-8-31(9-7-30)35-24-38-22-32-4-1-2-5-34(32)35/h1-2,4-9,22-25,27-29H,3,10-21,26H2
InChIKey WXQLBECTYSLDGB-UHFFFAOYSA-N
SMILES C1CN(CCN1CCCC23CC4CC(C2)CC(C4)C3)C(=O)CN5C=C(C=N5)C6=CC=C(C=C6)C7=CN=CC8=CC=CC=C87

Request a Quote